Cargando…
Safety and diagnostic efficacy of gadoteridol for magnetic resonance imaging of the brain and spine in children 2 years of age and younger
BACKGROUND: Neonates and young children require efficacious magnetic resonance imaging (MRI) examinations but are potentially more susceptible to the short- and long-term adverse effects of gadolinium-based contrast agents due to the immaturity of their body functions. OBJECTIVE: To evaluate the acu...
Autores principales: | Shah, Chetan C., Spampinato, Maria Vittoria, Parmar, Hemant A., Raslan, Osama A., Tomà, Paolo, Lin, Doris D. M., Vymazal, Josef, Colosimo, Cesare, Enterline, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426253/ https://www.ncbi.nlm.nih.gov/pubmed/33950270 http://dx.doi.org/10.1007/s00247-021-05069-w |
Ejemplares similares
-
Prospective Multicenter Study of the Safety of Gadoteridol in 6163 Patients
por: Cho, Sung Bum, et al.
Publicado: (2019) -
The MRI Contrast Agent Gadoteridol Enhances Distribution of rAAV1 in the Rat Hippocampus
por: Hullinger, Rikki, et al.
Publicado: (2013) -
Dose‐Lowering in Contrast‐Enhanced MRI of the Central Nervous System: A Retrospective, Parallel‐Group Comparison Using Gadobenate Dimeglumine
por: DeLano, Mark C., et al.
Publicado: (2021) -
Two-colour serial femtosecond crystallography dataset from gadoteridol-derivatized lysozyme for MAD phasing
por: Gorel, Alexander, et al.
Publicado: (2017) -
The TRUTH confirmed: validation of an intraindividual comparison of gadobutrol and gadoteridol for imaging of glioblastoma using quantitative enhancement analysis
por: Kuhn, Matthew J., et al.
Publicado: (2021)